Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ana Barajas is active.

Publication


Featured researches published by Ana Barajas.


The Scientific World Journal | 2015

Gender differences in individuals at high-risk of psychosis: a comprehensive literature review.

Ana Barajas; Susana Ochoa; Jordi E. Obiols; Lluís Lalucat-Jo

Introduction. To date, few studies have focused on the characterization of clinical phenomenology regarding gender in population at high-risk of psychosis. This paper is an attempt to summarize the findings found in the scientific literature regarding gender differences in high-risk populations, taking into account parameters studied in populations with schizophrenia and other psychotic disorders, such as incidence, clinical expression, duration of untreated illness (DUI), social functioning, and cognitive impairment prior to full-blown psychosis development. Method. Studies were systematically searched in PubMed. Studies using gender variable as a control variable were excluded. 12 studies met inclusion criteria. Results. Most of the studies found a differential pattern between women and men as regards clinical, social, and cognitive variables in the prodromal phase, with worse performance in men except in cognitive functioning (more severe negative symptoms, worse social functioning, and longer DUI in men). Similar conversion rates over time were found between men and women. Conclusions. Many of the studies analyzed suggest that differences between men and women in the expression of psychosis extend across a continuum, from the subclinical forms of illness to the debut of psychosis. However, the small number of studies and their significant methodological and clinical limitations do not allow for firm conclusions.


Schizophrenia Research | 2013

Three-factor model of premorbid adjustment in a sample with chronic schizophrenia and first-episode psychosis

Ana Barajas; Judith Usall; Iris Baños; Montserrat Dolz; Victoria Villalta-Gil; Miriam Vilaplana; Jaume Autonell; Bernardo Sánchez; Jorge A. Cervilla; Alexandrina Foix; Jordi E. Obiols; Josep Maria Haro; Susana Ochoa

BACKGROUND The dimensionality of premorbid adjustment (PA) has been a debated issue, with attempts to determine whether PA is a unitary construct or composed of several independent domains characterized by a differential deterioration pattern and specific outcome correlates. AIMS This study examines the factorial structure of PA, as well as, the course and correlates of its domains. METHOD Retrospective study of 84 adult patients experiencing first-episode psychosis (FEP) (n=33) and individuals with schizophrenia (SCH) (n=51). All patients were evaluated with a comprehensive battery of instruments including clinical, functioning and neuropsychological variables. A principal component analysis accompanied by a varimax rotation method was used to examine the factor structure of the PAS-S scale. Paired t tests and Wilcoxon rank tests were used to assess the changes in PAS domains over time. Bivariate correlation analyses were performed to analyse the relationship between PAS factors and clinical, social and cognitive variables. RESULTS PA was better explained by three factors (71.65% of the variance): Academic PA, Social PA and Socio-sexual PA. The academic domain showed higher scores of PA from childhood. Social and clinical variables were more strongly related to Social PA and Socio-sexual PA domains, and the Academic PA domain was exclusively associated with cognitive variables. CONCLUSION This study supports previous evidence, emphasizing the validity of dividing PA into its sub-components. A differential deterioration pattern and specific correlates were observed in each PA domains, suggesting that impairments in each PA domain might predispose individuals to develop different expressions of psychotic dimensions.


Schizophrenia Research | 2013

Cognitive profiles of three clusters of patients with a first-episode psychosis

Susana Ochoa; Elena Huerta-Ramos; Ana Barajas; Raquel Iniesta; Montserrat Dolz; Iris Baños; Bernardo Sánchez; Janina Carlson; Alexandrina Foix; Trinidad Pelaez; Marta Coromina; Marta Pardo; Judith Usall

OBJECTIVE The primary objective was to identify specific groups of patients with a first-episode psychosis based on family history, obstetric complications, neurological soft signs, and premorbid functioning. The secondary objective was to relate these groups with cognitive variables. METHOD A total of 62 first-episode psychoses were recruited from adult and child and adolescent mental health services. The inclusion criteria were patients between 7 and 65 years old (real range of the samples was 13-35 years old), two or more psychotic symptoms and less than one year from the onset of the symptoms. Premorbid functioning (PAS), soft signs (NES), obstetric complications and a neuropsychological battery (CPT, TMTA/TMTB, TAVEC/TAVECI, Stroop, specific subtest of WAIS-III/WISC-IV) were administered. RESULTS We found three clusters: 1) higher neurodevelopment contribution (N=14), 2) higher genetic contribution (N=30), and 3) lower neurodevelopment contribution (N=18). Statistical differences were found between groups in TMTB, learning curve of the TAVEC, digits of the WAIS and premorbid estimated IQ, the cluster 1 being the most impaired. CONCLUSIONS A cluster approach could differentiate several groups of patients with different cognitive performance. Neuropsychological interventions, as cognitive remediation, should be addressed specifically to patients with more impaired results.


Comprehensive Psychiatry | 2013

Spanish validation of the Premorbid Adjustment Scale (PAS-S)

Ana Barajas; Susana Ochoa; Iris Baños; Montse Dolz; Victoria Villalta-Gil; Miriam Vilaplana; Jaume Autonell; Bernardo Sánchez; Jorge A. Cervilla; Alexandrina Foix; Jordi E. Obiols; Josep Maria Haro; Judith Usall

BACKGROUND The Premorbid Adjustment Scale (PAS) has been the most widely used scale to quantify premorbid status in schizophrenia, coming to be regarded as the gold standard of retrospective assessment instruments. AIMS To examine the psychometric properties of the Spanish version of the PAS (PAS-S). METHOD Retrospective study of 140 individuals experiencing a first episode of psychosis (n=77) and individuals who have schizophrenia (n=63), both adult and adolescent patients. Data were collected through a socio-demographic questionnaire and a battery of instruments which includes the following scales: PAS-S, PANSS, LSP, GAF and DAS-sv. The Cronbachs alpha was performed to assess the internal consistency of PAS-S. Pearsons correlations were performed to assess the convergent and discriminant validity. RESULTS The Cronbachs alpha of the PAS-S scale was 0.85. The correlation between social PAS-S and total PAS-S was 0.85 (p<0.001); while for academic PAS-S and total PAS-S it was 0.53 (p<0.001). Significant correlations were observed between all the scores of each age period evaluated across the PAS-S scale, with a significance value less than 0.001. There was a relationship between negative symptoms and social PAS-S (0.20, p<0.05) and total PAS-S (0.22, p<0.05), but not with academic PAS-S. However, there was a correlation between academic PAS-S and general subscale of the PANSS (0.19, p<0.05). Social PAS-S was related to disability measures (DAS-sv); and academic PAS-S showed discriminant validity with most of the variables of social functioning. PAS-S did not show association with the total LSP scale (discriminant validity). CONCLUSION The Spanish version of the Premorbid Adjustment Scale showed appropriate psychometric properties in patients experiencing a first episode of psychosis and who have a chronic evolution of the illness. Moreover, each domain of the PAS-S (social and academic premorbid functioning) showed a differential relationship to other characteristics such as psychotic symptoms, disability or social functioning after onset of illness.


Psychopharmacology | 2016

Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use

Christian Núñez; Susana Ochoa; Elena Huerta-Ramos; Iris Baños; Ana Barajas; Montserrat Dolz; Bernardo Sánchez; Núria Del Cacho; Judith Usall

RationaleFirst episode patients and patients with schizophrenia exhibit increased rates of cannabis use compared to the general population. Contrary to what has been reported in studies with healthy people, most of the published studies so far have reported no impairments or even beneficial effects on neurocognition associated with cannabis consumption in psychotic patients. However, these studies did not address the effects of very high cannabis consumption.ObjectivesOur aim in this study was to assess the effects on neurocognition of medium and heavy cannabis consumption in first psychotic episode patients.MethodsA total of 74 patients were included in the study and assigned to three different groups according to their mean cannabis consumption during the last year (non-users, medium users, and heavy users). Participants were administered verbal memory and other neurocognitive tasks.ResultsHeavy cannabis users were significantly impaired in all the verbal memory measures with respect to non-users, including immediate (p = .026), short-term (p = .005), and long-term (p = .002) memory. There were no significant differences between medium and non-users. Moreover, non-users performed better than all cannabis users in the arithmetic task (p = .020). Heavy cannabis consumption was associated with more commission errors in the continuous performance task (CPT) (p = .008) and more time to complete trail making test A (TMT-A) (p = .008), compared to the group of medium users.ConclusionsHeavy cannabis consumption seems to impair verbal memory in first psychotic episode patients. Heavy users also perform worse than medium users in other neurocognitive tasks. Based on the results and the available evidence, a dose-related effect of cannabis consumption is suggested.


Comprehensive Psychiatry | 2016

Differential effects of sex on substance use between first episode psychosis patients and healthy people

Christian Núñez; Susana Ochoa; Elena Huerta-Ramos; Iris Baños; Ana Barajas; Montserrat Dolz; Bernardo Sánchez; Núria Del Cacho; Judith Usall

BACKGROUND Substance use in psychosis is an important field of study given that it can be a risk factor for the development of psychosis and can give rise to psychotic symptoms. Studies of substance use in first episode psychosis patients do not frequently assess non-pathological substance consumption among patients, but rather the prevalence of substance abuse or dependence disorders. Moreover, most of these studies do not address the effects of sex in sufficient depth, and the consumption of caffeine or tobacco, which are two of the most frequently used substances, is often not assessed. OBJECTIVES The aim of this study was to compare patterns and quantities of substance use between first episode psychosis patients and healthy controls and between men and women, and explore the potential interactive effects between group (patients or controls) and sex. METHODS A total of 158 participants (82 first episode psychosis patients and 76 healthy controls) were included in the study. Both adults and adolescents were included in the study. Frequency and amount of use of caffeine, tobacco, alcohol, cannabis, cocaine, hallucinogens, stimulants, and opiates were gathered. RESULTS A significant main effect of sex was found for the frequency of use of tobacco (p=.050). Main effects of group were found for the quantity of tobacco (p<.001) and cannabis (p<.001) consumed, as well as main effects of sex for the quantity of alcohol (p=.003) and cannabis (p=.017) consumed. There were also interaction effects between group and sex for the frequency of use of tobacco (p=.005) and cannabis (p=.009), and for the amount of cannabis consumed (p=.049). Qualitative differences between males and females regarding combined substance use are also reported. CONCLUSIONS Among patients, men used tobacco more frequently than women, but this sex difference was not the same for the control group, in which women smoked more often than men. Regarding cannabis, men smoked cannabis more frequently and in larger amounts than women, but only in the patients group, whereas no sex differences for cannabis were found for the controls. Main effects of group and sex for tobacco and alcohol, as well as the lack of differences for the frequency and amount of use of caffeine, are also commented. This is the first study to assess the different effects of sex on substance use in first episode psychosis patients and healthy controls.


Psiquiatría Biológica | 2007

Edad de inicio del primer episodio psicótico: ¿hay diferencias clínicas entre varones y mujeres?☆

Ana Barajas; Iris Baños; Susana Ochoa; Judith Usall; Vicky Villalta; Montse Dolz; Bernardo Sánchez; Josep Maria Haro; Grupo Genipe

Introduccion En la ultima decada, los estudios sobre primeros episodios psicoticos han alcanzado relevancia. En nuestro estudio se analizan las diferencias por sexo en la edad de inicio, asi como las diferencias en el tipo y la gravedad de los sintomas psicoticos en funcion de la edad de inicio, en varones y mujeres con un primer episodio psicotico. Material y metodo Estudio transversal de 24 casos consecutivos con un primer episodio psicotico. Criterios de inclusion: dos o mas sintomas psicoticos; edad comprendida entre 7 y 65 anos; primera consulta en el centro de estudio; menos de 6 meses desde el primer contacto con los servicios. Los instrumentos utilizados fueron un cuestionario clinico y sociodemografico, la PANSS y la ICG-ESQ. Para el analisis de los datos se ha utilizado la prueba de U Mann-Whitney para datos no parametricos, del SPSS. Resultados En nuestra muestra, el 66,7% eran varones y el 41,7% tenia una edad Conclusiones Se evidencia un patron de inicio del episodio psicotico en varones adolescentes con predominio de sintomatologia negativa. Este patron de inicio con sintomas negativos se suma a las evidencias encontradas en otros estudios a lo largo de los anos que apoyan la hipotesis del neurodesarrollo.


Psychiatry Research-neuroimaging | 2016

Incidence of stressful life events and influence of sociodemographic and clinical variables on the onset of first-episode psychosis

Anna Butjosa; Juana Gómez-Benito; Elena Huerta-Ramos; Núria Del Cacho; Ana Barajas; Iris Baños; Judith Usall; Montserrat Dolz; Bernardo Sánchez; Janina Carlson; Josep Maria Haro; Susana Ochoa

This study presents a quantitative analysis of the incidence of stressful life events (SLEs) and the variables gender, age at onset, family history and psychotic symptoms in patients with first-episode psychosis (FEP). A descriptive, cross-sectional methodology was used to interview 68 patients with FEP between 13 and 47 years of age. The Psychiatric Epidemiology Research Interview Life Events Scale collected one-year period prior to onset of FEP - used to analyse the subcategories academic, work, love and marriage, children, residence, legal affairs, finances and social activities-, Positive and Negative Syndrome Scale, and Clinical Global Impression-Schizophrenia scale were used to assess the relevance of certain SLEs during adolescence. Age at onset showed a significant negative correlation with the categories academic and social activities. By contrast, it showed a positive correlation with work and children. A significant relationship was found between paternal family history and social activities and between maternal family history and academic and love and marriage. Finally, an inverse relationship was observed between negative symptoms and the categories children and finance. Depressive symptoms were significantly correlated with the category academic. Our results show the importance of SLEs during adolescence and suggest that there is a clear need to develop preventive actions that promote effective strategies for dealing with the accumulation of psychosocial stress.


Psychiatry Research-neuroimaging | 2016

Influence of cognition, premorbid adjustment and psychotic symptoms on psycho-social functioning in first-episode psychosis

Norma Grau; Elena Rubio-Abadal; Judith Usall; Ana Barajas; Anna Butjosa; Montserrat Dolz; Iris Baños; Bernardo Sánchez; Maria J. Rodriguez; Trinidad Pelaez; Stephanie Sammut; Janina Carlson; Elena Huerta-Ramos; Susana Ochoa

OBJECTIVE The aim of this study is to evaluate the relationship between psycho-social functioning and symptoms, cognitive function, and premorbid adjustment, in patients with a first-episode psychosis. METHOD Clinical data were obtained from 90 patients, who were assessed with the Disability Assessment Scale (DAS-sv), the Positive and Negative Syndrome Scale (PANSS), the Premorbid Adjustment Scale (PAS-S) and with a battery of cognitive tests including Trail Making Tests A and B (TMTA- B), Continous Performance Test (CPT), some subscales of the Wechler Adult Intelligence Scale (WAIS), and the Verbal Learning Test España-Complutense (TAVEC). RESULTS The results of the study suggest that psycho-social functioning in first-episode psychosis is significantly related to: positive, negative, excitative, affective and disorganized symptoms, social premorbid adjustment, cognitive flexibility, working memory, short term and long term memory. Of these, those which best explained psycho-social functioning are the positive and excitative symptoms, premorbid adjustment, flexibility and memory. CONCLUSIONS These findings highlight the importance early intervention on cognitive and clinical variables to help provide a better psycho-social functioning in people with a first-episode of psychosis.


Psychological Medicine | 2017

Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis

Susana Ochoa; Raquel López-Carrilero; Maria Luisa Barrigón; Esther Pousa; Ana Barajas; E. Lorente-Rovira; Fermín González-Higueras; Eva Grasa; Isabel Ruiz-Delgado; Jordi Cid; I. Birulés; I. Esteban-Pinos; R. Casañas; A. Luengo; P. Torres-Hernández; I. Corripio; M. Montes-Gámez; M. Beltran; A. De Apraiz; L. Domínguez-Sánchez; E. Sánchez; B. Llacer; Trinidad Pelaez; J. L. Bogas; S. Moritz

BACKGROUND Aims were to assess the efficacy of metacognitive training (MCT) in people with a recent onset of psychosis in terms of symptoms as a primary outcome and metacognitive variables as a secondary outcome. METHOD A multicenter, randomized, controlled clinical trial was performed. A total of 126 patients were randomized to an MCT or a psycho-educational intervention with cognitive-behavioral elements. The sample was composed of people with a recent onset of psychosis, recruited from nine public centers in Spain. The treatment consisted of eight weekly sessions for both groups. Patients were assessed at three time-points: baseline, post-treatment, and at 6 months follow-up. The evaluator was blinded to the condition of the patient. Symptoms were assessed with the PANSS and metacognition was assessed with a battery of questionnaires of cognitive biases and social cognition. RESULTS Both MCT and psycho-educational groups had improved symptoms post-treatment and at follow-up, with greater improvements in the MCT group. The MCT group was superior to the psycho-educational group on the Beck Cognitive Insight Scale (BCIS) total (p = 0.026) and self-certainty (p = 0.035) and dependence self-subscale of irrational beliefs, comparing baseline and post-treatment. Moreover, comparing baseline and follow-up, the MCT group was better than the psycho-educational group in self-reflectiveness on the BCIS (p = 0.047), total BCIS (p = 0.045), and intolerance to frustration (p = 0.014). Jumping to Conclusions (JTC) improved more in the MCT group than the psycho-educational group (p = 0.021). Regarding the comparison within each group, Theory of Mind (ToM), Personalizing Bias, and other subscales of irrational beliefs improved in the MCT group but not the psycho-educational group (p < 0.001-0.032). CONCLUSIONS MCT could be an effective psychological intervention for people with recent onset of psychosis in order to improve cognitive insight, JTC, and tolerance to frustration. It seems that MCT could be useful to improve symptoms, ToM, and personalizing bias.

Collaboration


Dive into the Ana Barajas's collaboration.

Top Co-Authors

Avatar

Susana Ochoa

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Iris Baños

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Judith Usall

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Montserrat Dolz

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Elena Huerta-Ramos

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar

Esther Pousa

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Susana Ochoa

Instituto de Salud Carlos III

View shared research outputs
Researchain Logo
Decentralizing Knowledge